Williams Timothy — SEC Form 4 filings

SEC reporting owner CIK 1748392. 7 Form 4 filings on record with FilingPulse; latest filed 2026-04-14.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-21 to 2026-04-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Vanda Pharmaceuticals Inc. (VNDA)SVP & General Counsel63 legs · 59,522 sh · $424,0684
GERON CORP (GERN)EVP and Chief Legal Officer11

Form 4 filings — Williams Timothy

FiledFormIssuerReported transactionsSource
2026-04-144GERON CORP (GERN)Grant/award (A): 2,500,000 (derivative) @ $0EDGAR
2026-03-044Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 42,434 @ $8.27EDGAR
2026-02-194Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR
2025-03-044Vanda Pharmaceuticals Inc. (VNDA)Tax withholding (F): 26,941 @ $4.76EDGAR
2025-02-204Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR
2024-03-064Vanda Pharmaceuticals Inc. (VNDA)Sale (S): 8,147 @ $4.41 · Sale (S): 8,941 @ $4.18EDGAR
2024-02-214Vanda Pharmaceuticals Inc. (VNDA)Grant/award (A): 125,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748392 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →